Prevention of infection due to Pneumocystis carinii

被引：85
作者：
Fishman, JA
机构：
[1] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 05期
关键词：
D O I：
10.1128/AAC.42.5.995
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：995 / 1004
页数：10
相关论文
共 144 条
[1]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[2]   AEROSOLIZED PENTAMIDINE, COTRIMOXAZOLE AND DAPSONE PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA AND TOXOPLASMIC ENCEPHALITIS [J].
ANTINORI, A ;
MURRI, R ;
AMMASSARI, A ;
DELUCA, A ;
LANZALONE, A ;
CINGOLANI, A ;
DAMIANO, F ;
MAIURO, G ;
VECCHIET, J ;
SCOPPETTUOLO, G ;
TAMBURRINI, E ;
ORTONA, L .
AIDS, 1995, 9 (12) :1343-1350
[3]   Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients [J].
Arend, SM ;
Westendorp, RGJ ;
Kroon, FP ;
vantWout, JW ;
Vandenbroucke, JP ;
vanEs, LA ;
vanderWoude, FJ .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (06) :920-925
[4]   SYNTHESIS, STABILITY, AND BIOLOGICAL EVALUATION OF WATER-SOLUBLE PRODRUGS OF A NEW ECHINOCANDIN LIPOPEPTIDE - DISCOVERY OF A POTENTIAL CLINICAL AGENT FOR THE TREATMENT OF SYSTEMIC CANDIDIASIS AND PNEUMOCYSTIS-CARINII PNEUMONIA (PCP) [J].
BALKOVEC, JM ;
BLACK, RM ;
HAMMOND, ML ;
HECK, JV ;
ZAMBIAS, RA ;
ABRUZZO, G ;
BARTIZAL, K ;
KROPP, H ;
TRAINOR, C ;
SCHWARTZ, RE ;
MCFADDEN, DC ;
NOLLSTADT, KH ;
PITTARELLI, LA ;
POWLES, MA ;
SCHMATZ, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) :194-198
[5]   Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia [J].
Barber, BA ;
Pegram, PS ;
High, KP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :718-722
[6]   INFECTIONS IN HUMAN LIVER RECIPIENTS - DIFFERENT PATTERNS EARLY AND LATE AFTER TRANSPLANTATION [J].
BARKHOLT, L ;
ERICZON, BG ;
TOLLEMAR, J ;
MALMBORG, AS ;
EHRNST, A ;
WILCZEK, H ;
ANDERSSON, J .
TRANSPLANT INTERNATIONAL, 1993, 6 (02) :77-84
[7]   NEW RAT MODEL OF PNEUMOCYSTIS-CARINII INFECTION [J].
BARTLETT, MS ;
FISHMAN, JA ;
QUEENER, SF ;
DURKIN, MM ;
JAY, MA ;
SMITH, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (06) :1100-1102
[8]   EVALUATION OF POTENT INHIBITORS OF DIBYDROFOLATE REDUCTASE IN A CULTURE MODEL FOR GROWTH OF PNEUMOCYSTIS-CARINII [J].
BARTLETT, MS ;
SHAW, M ;
NAVARAN, P ;
SMITH, JW ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2436-2441
[9]   PNEUMOCYSTIS-CARINII IS RESISTANT TO IMIDAZOLE ANTIFUNGAL AGENTS [J].
BARTLETT, MS ;
QUEENER, SF ;
SHAW, MM ;
RICHARDSON, JD ;
SMITH, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) :1859-1861
[10]   COMPARISON OF CORTICOSTEROID AND L3T4(+) ANTIBODY IMMUNOSUPPRESSED MOUSE MODELS OF PNEUMOCYSTIS-CARINII PNEUMONIA FOR EVALUATION OF DRUGS AND LEUKOCYTES [J].
BARTLETT, MS ;
CURRENT, WL ;
ORAZI, A ;
BAUER, NL ;
NEIMAN, RS ;
QUEENER, SF ;
SMITH, JW .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (05) :511-516
12345678910